Acquisitions, Collaborations, and Agreements were the Key Growth Strategies Adopted by Players Operating in the High-Resolution Melting Analysis Market
An analysis of the market developments between 2013 and 2017 revealed that acquisitions, collaborations, and agreements were the most important growth strategies employed by market leaders in this period.
The other important growth strategies adopted by players in this market were organic strategies like product launches and enhancements. These strategies were adopted by market players to enhance their product portfolio. Bio-Rad Laboratories (U.S.) and Agilent Technologies Inc. (U.S.) adopted these strategies to strengthen their market share.
In 2015, the high-resolution melting analysis market was dominated by Thermo Fisher Scientific Inc. (U.S.), F. Hofmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories (U.S.), and QIAGEN N.V. (Netherlands). An analysis of the developments of these companies in the last three years suggests that the companies have undertaken various organic and inorganic strategies to expand their market shares and move ahead of their competitors.
Thermo Fisher Scientific Inc. (U.S.) is the largest player in the global high-resolution melting analysis market. In order to remain competitive, the company adopted inorganic and organic growth strategies such as acquisitions, collaborations, and expansions for enhancing its presence in the market. For instance, in 2014, the company acquired Life Technologies Corporation (U.S.), a leading player in the life science market to strengthen its product offerings. Similarly, in May 2015, the company started its customer experience center in the Middle East to support the life science segment of the company. This expansion was aimed at capturing the developing Middle East market.
F. Hoffmann-La Roche AG (Switzerland) is the second largest player in the global high-resolution melting market. The company has maintained its leadership position by focusing on inorganic growth strategies such as collaborations and acquisitions to expand its product portfolio and product development capabilities. For instance, in February 2012, Roche Ltd. entered into a product licensing agreement with Life Technologies Corporation (U.S.). According to the agreement, Roche licensed its real-time PCR technology patent to Life Technologies Corporation. The agreement also covered right to use of high-resolution melting-curve analysis (HRM) technology of Roche in the diagnostics field.
Other companies present in the HRM market include Agilent Technologies Inc. (U.S.), bioMérieux S.A. (France), Illumina, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Novacyt (France), Azura Genomics (U.S.), Canon Biomedical (U.S.), and PREMIER Biosoft (U.S.), among others.
Related Reports:
High-Resolution Melting Analysis Market by Product (Supermix Reagent, RT PCR Instrument, Software), Application (SNP Genotyping, Mutation Discovery, Epigenetics), Enduser (Research Laboratories, Hospital, Diagnostic Center) - Global Forecast to 2021
Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
